Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial
Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page
- Check3 days agoChange DetectedUpdated the page from Revision: v3.0.1 to Revision: v3.0.2; removed the old revision tag and the 'Back to Top' element.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, specifically retaining the name and location of Mt. Pleasant, South Carolina, while also adding drug information for Risankizumab and its relevance to skin and connective tissue diseases.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.